A One Health approach to prevention, treatment, and control of campylobacteriosis

• Autores: Schiaffino F., Platts-Mills J., Kosek M.N.
• Formato: artículo
• Fecha de Publicación: 2019
• Institución: Consejo Nacional de Ciencia Tecnología e Innovación
• Repositorio: CONCYTEC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.concytec.gob.pe:20.500.12390/2694
• Enlace del recurso: https://hdl.handle.net/20.500.12390/2694; https://doi.org/10.1097/QCO.0000000000000570
• Nivel de acceso: acceso abierto
• Materia: vaccines; antimicrobial resistance; Campylobacter spp.; One Health; http://purl.org/pe-repo/ocde/ford#4.02.01

Purpose of review: To review recent findings regarding the control and treatment of campylobacteriosis. Recent findings: The application of improved diagnostics has led to an upward shift in the attributable burden of Campylobacter infections, in both the United States and Europe as well as in resource-poor settings. Increased focus has brought a fundamental feature of campylobacteriosis - the ability to cause relapsing disease back into focus, and expanding data on antimicrobial resistance has lead from a switch in first-line therapy for severe diarrhea from quinolones to azithromycin in most contexts, even as evidence of expanding macrolide resistance emerges. Summary: Campylobacter spp. infection is a common infection worldwide. Antibiotic-resistant Campylobacter spp. has become an emerging threat with the increase in industrial poultry production, as well as the broad use of antibiotics in both animals and humans. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.